Meso Numismatics, Inc. reported sales results for the year 2023. The company closed its 2023 fiscal year with approximately $2.4 million in sales, a more than 50% increase over 2022 levels. Sales were derived from its 4 main channels, Training, Product sales, Equipment sales and Patient procedures.
Regenerative Medical Technology Group Inc.
Equities
MSSV
US59071L1035
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0351 USD | -27.80% | -12.25% | +380.82% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+380.82% | 438K | |
+46.03% | 55.66B | |
-7.53% | 38.98B | |
+36.10% | 38.8B | |
-9.38% | 27.32B | |
+12.31% | 26.29B | |
-16.38% | 20.25B | |
+30.79% | 12.76B | |
+28.57% | 12.18B | |
-0.36% | 12.12B |
- Stock Market
- Equities
- MSSV Stock
- News Regenerative Medical Technology Group Inc.
- Meso Numismatics, Inc. Reports Sales Results for the Year 2023